These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30685326)

  • 1. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
    de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
    Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pelvic and para-aortic lymphadenectomy versus para-aortic lymphadenectomy alone for locally advanced FIGO stage IB2 to IIB cervical cancer using a propensity score matching analysis: Results from the FRANCOGYN study group.
    Bendifallah S; de Foucher T; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Huguet F; Graesslin O; Touboul C; Collinet P; Huchon C; Daraï E; Ballester M;
    Eur J Surg Oncol; 2018 Dec; 44(12):1921-1928. PubMed ID: 30213717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
    Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
    Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
    Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
    Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
    Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of first recurrence and outcomes in surgically treated women with vulvar cancer: results from FRANCOGYN study group.
    Pirot F; Chaltiel D; Ouldamer L; Touboul C; Raimond E; Carcopino X; Daraï E; Bendifallah S
    J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101775. PubMed ID: 32438137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer recurrence: Proposal for a classification based on anatomical dissemination pathways and prognosis.
    Bendifallah S; de Foucher T; Bricou A; Ouldamer L; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Huguet F; Graesslin O; Touboul C; Collinet P; Huchon C; Daraï E; Ballester M;
    Surg Oncol; 2019 Sep; 30():40-46. PubMed ID: 31500783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive chemoradiotherapy for cervical cancer: A 11-year population-based study.
    Kalampokas E; Macdonald G; Young H; Bednarek A; Kennedy AM; Cairns M; Parkin DE
    Eur J Cancer Care (Engl); 2020 May; 29(3):e13223. PubMed ID: 31944444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of preoperative vaginal intracavitary irradiation for Stage Ib2 and IIa cervical cancer.
    Li F; Wu Y; Kong W; Wang J; Hao X; Niu J; Bai L
    J Cancer Res Ther; 2017; 13(5):796-800. PubMed ID: 29237906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis impact of posttreatment pelvic MRI in patients treated for stage IB2-IIB cervical cancer with chemoradiation therapy.
    Moussilmani T; Knight S; Mancini J; Touboul C; Rodriguez F; Bolze PA; Bendifallah S; Ballester M; Collinet P; Kerbage Y; Ouldamer L; Atrous G; Lavoué V; Dion L; Dabi Y; Raimond E; Graesslin O; Huchon C; Mimouni M; Bricou A; Golfier F; Carcopino X
    Eur J Surg Oncol; 2021 May; 47(5):1103-1110. PubMed ID: 33160780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
    Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Taarnhøj GA; Christensen IJ; Lajer H; Fuglsang K; Jeppesen MM; Kahr HS; Høgdall C
    Cancer; 2018 Mar; 124(5):943-951. PubMed ID: 29211304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.